| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Arrest | 45 | 2025 | 351 | 8.540 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 14 | 2024 | 88 | 4.050 |
Why?
|
| Cardiopulmonary Resuscitation | 24 | 2024 | 314 | 3.800 |
Why?
|
| Nitrites | 10 | 2020 | 45 | 3.260 |
Why?
|
| Sodium Nitrite | 5 | 2021 | 6 | 1.660 |
Why?
|
| Emergency Medical Services | 8 | 2024 | 436 | 1.530 |
Why?
|
| Drowning | 4 | 2024 | 38 | 1.400 |
Why?
|
| Hypothermia, Induced | 10 | 2023 | 166 | 1.200 |
Why?
|
| Hospital Mortality | 8 | 2021 | 1020 | 1.190 |
Why?
|
| Analgesics, Opioid | 3 | 2021 | 408 | 1.170 |
Why?
|
| American Heart Association | 3 | 2024 | 299 | 1.170 |
Why?
|
| Coma | 6 | 2020 | 55 | 1.100 |
Why?
|
| Neuroprotective Agents | 4 | 2017 | 156 | 1.080 |
Why?
|
| Ischemic Preconditioning | 2 | 2017 | 19 | 0.960 |
Why?
|
| Ventricular Fibrillation | 4 | 2021 | 52 | 0.900 |
Why?
|
| Nitric Oxide | 6 | 2020 | 444 | 0.890 |
Why?
|
| Drug Overdose | 2 | 2020 | 65 | 0.830 |
Why?
|
| Brain | 8 | 2021 | 3005 | 0.800 |
Why?
|
| Cross Infection | 5 | 2012 | 331 | 0.770 |
Why?
|
| Near Drowning | 3 | 2024 | 26 | 0.760 |
Why?
|
| Surge Capacity | 1 | 2020 | 9 | 0.700 |
Why?
|
| Intensive Care Units, Pediatric | 3 | 2020 | 477 | 0.680 |
Why?
|
| Mitochondria | 7 | 2022 | 689 | 0.670 |
Why?
|
| Pediatricians | 1 | 2020 | 66 | 0.660 |
Why?
|
| Advanced Cardiac Life Support | 2 | 2020 | 16 | 0.660 |
Why?
|
| Brain Ischemia | 5 | 2018 | 258 | 0.650 |
Why?
|
| Humans | 77 | 2025 | 124311 | 0.650 |
Why?
|
| Coronary Occlusion | 1 | 2019 | 27 | 0.650 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2020 | 79 | 0.640 |
Why?
|
| Vasoconstrictor Agents | 4 | 2021 | 136 | 0.640 |
Why?
|
| Coronary Angiography | 2 | 2019 | 427 | 0.630 |
Why?
|
| Intensive Care Units | 6 | 2016 | 483 | 0.620 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 357 | 0.590 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 373 | 0.590 |
Why?
|
| Aftercare | 2 | 2016 | 147 | 0.590 |
Why?
|
| Shock | 2 | 2016 | 90 | 0.580 |
Why?
|
| Neuroprotection | 2 | 2022 | 26 | 0.580 |
Why?
|
| Carbon Dioxide | 1 | 2018 | 273 | 0.580 |
Why?
|
| Blood Pressure | 4 | 2021 | 1322 | 0.570 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2019 | 108 | 0.570 |
Why?
|
| Myocardium | 3 | 2021 | 997 | 0.570 |
Why?
|
| Thigh | 1 | 2017 | 51 | 0.540 |
Why?
|
| Arm | 1 | 2017 | 80 | 0.540 |
Why?
|
| Asphyxia | 4 | 2021 | 14 | 0.540 |
Why?
|
| Rats, Sprague-Dawley | 11 | 2021 | 1231 | 0.530 |
Why?
|
| Heart | 4 | 2023 | 718 | 0.520 |
Why?
|
| Electron Transport Complex I | 2 | 2020 | 32 | 0.500 |
Why?
|
| Catheterization, Central Venous | 3 | 2012 | 134 | 0.500 |
Why?
|
| Sepsis | 3 | 2023 | 480 | 0.490 |
Why?
|
| Hypertension, Pulmonary | 1 | 2020 | 433 | 0.490 |
Why?
|
| Hyperoxia | 4 | 2020 | 129 | 0.480 |
Why?
|
| Hyperlactatemia | 1 | 2014 | 2 | 0.470 |
Why?
|
| Thiamine | 1 | 2014 | 8 | 0.470 |
Why?
|
| Thiamine Deficiency | 1 | 2014 | 4 | 0.470 |
Why?
|
| Random Allocation | 6 | 2020 | 436 | 0.470 |
Why?
|
| Thrombolytic Therapy | 1 | 2016 | 204 | 0.460 |
Why?
|
| Respiration, Artificial | 6 | 2020 | 459 | 0.460 |
Why?
|
| Vitamin B Complex | 1 | 2014 | 41 | 0.450 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2014 | 113 | 0.450 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2017 | 233 | 0.450 |
Why?
|
| Critical Illness | 5 | 2023 | 598 | 0.440 |
Why?
|
| Male | 46 | 2025 | 60976 | 0.430 |
Why?
|
| Venous Thromboembolism | 1 | 2016 | 160 | 0.430 |
Why?
|
| Forecasting | 1 | 2015 | 351 | 0.430 |
Why?
|
| Ischemic Postconditioning | 1 | 2012 | 4 | 0.420 |
Why?
|
| Withholding Treatment | 2 | 2025 | 68 | 0.410 |
Why?
|
| Reactive Oxygen Species | 3 | 2020 | 492 | 0.410 |
Why?
|
| Disease Management | 1 | 2016 | 519 | 0.400 |
Why?
|
| Hypothermia | 2 | 2023 | 55 | 0.390 |
Why?
|
| Reperfusion Injury | 2 | 2015 | 103 | 0.380 |
Why?
|
| Ventricular Function, Left | 1 | 2015 | 495 | 0.380 |
Why?
|
| Housekeeping, Hospital | 1 | 2011 | 2 | 0.370 |
Why?
|
| Anticoagulants | 1 | 2016 | 585 | 0.370 |
Why?
|
| Rats | 12 | 2022 | 3690 | 0.360 |
Why?
|
| Shock, Cardiogenic | 2 | 2023 | 192 | 0.350 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2014 | 219 | 0.350 |
Why?
|
| Ultraviolet Rays | 1 | 2011 | 204 | 0.340 |
Why?
|
| Veins | 1 | 2010 | 107 | 0.330 |
Why?
|
| Fluorescent Dyes | 1 | 2011 | 261 | 0.330 |
Why?
|
| Infection Control | 1 | 2011 | 160 | 0.330 |
Why?
|
| Disease Models, Animal | 9 | 2021 | 4355 | 0.330 |
Why?
|
| Animals | 26 | 2022 | 34154 | 0.320 |
Why?
|
| Comorbidity | 3 | 2020 | 1512 | 0.320 |
Why?
|
| Adult | 18 | 2025 | 29357 | 0.310 |
Why?
|
| Arteries | 1 | 2010 | 220 | 0.310 |
Why?
|
| Nervous System | 1 | 2009 | 127 | 0.310 |
Why?
|
| Signal Transduction | 6 | 2020 | 4534 | 0.310 |
Why?
|
| Female | 37 | 2025 | 66248 | 0.300 |
Why?
|
| Administration, Intravenous | 2 | 2019 | 143 | 0.300 |
Why?
|
| Superoxides | 2 | 2020 | 154 | 0.290 |
Why?
|
| Prospective Studies | 10 | 2025 | 6083 | 0.290 |
Why?
|
| Muscle Cells | 1 | 2007 | 24 | 0.280 |
Why?
|
| Life Support Care | 2 | 2025 | 46 | 0.280 |
Why?
|
| United States | 7 | 2024 | 10757 | 0.280 |
Why?
|
| Heart Failure | 1 | 2020 | 2154 | 0.280 |
Why?
|
| Middle Aged | 24 | 2025 | 26428 | 0.270 |
Why?
|
| Severity of Illness Index | 8 | 2021 | 2895 | 0.270 |
Why?
|
| Oxygen | 5 | 2020 | 554 | 0.260 |
Why?
|
| Heptanoic Acids | 1 | 2006 | 78 | 0.260 |
Why?
|
| Registries | 5 | 2018 | 1410 | 0.250 |
Why?
|
| Subclavian Vein | 1 | 2005 | 23 | 0.240 |
Why?
|
| Pennsylvania | 4 | 2020 | 52 | 0.240 |
Why?
|
| Healthcare Disparities | 1 | 2010 | 428 | 0.240 |
Why?
|
| Double-Blind Method | 4 | 2021 | 1618 | 0.240 |
Why?
|
| Monitoring, Physiologic | 2 | 2018 | 365 | 0.240 |
Why?
|
| Pyrroles | 1 | 2006 | 179 | 0.230 |
Why?
|
| Jugular Veins | 1 | 2005 | 76 | 0.230 |
Why?
|
| Femoral Vein | 1 | 2005 | 51 | 0.230 |
Why?
|
| Pneumonia | 2 | 2005 | 326 | 0.230 |
Why?
|
| Critical Care | 3 | 2020 | 650 | 0.230 |
Why?
|
| Hemodynamics | 3 | 2023 | 844 | 0.230 |
Why?
|
| Cardiomyopathies | 2 | 2019 | 479 | 0.230 |
Why?
|
| Electroencephalography | 2 | 2018 | 868 | 0.220 |
Why?
|
| Catheters, Indwelling | 1 | 2005 | 155 | 0.220 |
Why?
|
| Research Design | 2 | 2018 | 686 | 0.220 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2021 | 1687 | 0.210 |
Why?
|
| Hydrogen Peroxide | 2 | 2022 | 113 | 0.210 |
Why?
|
| Drainage | 1 | 2005 | 257 | 0.210 |
Why?
|
| Cerebrovascular Circulation | 2 | 2018 | 433 | 0.210 |
Why?
|
| Protein Kinase C-delta | 2 | 2014 | 17 | 0.210 |
Why?
|
| Resuscitation | 3 | 2020 | 246 | 0.200 |
Why?
|
| Pandemics | 2 | 2020 | 1101 | 0.200 |
Why?
|
| Cross-Over Studies | 3 | 2021 | 312 | 0.200 |
Why?
|
| Heart Rate | 2 | 2017 | 588 | 0.200 |
Why?
|
| Cold Temperature | 2 | 2023 | 78 | 0.200 |
Why?
|
| Survival Analysis | 4 | 2021 | 1482 | 0.200 |
Why?
|
| Recovery of Function | 3 | 2025 | 440 | 0.190 |
Why?
|
| Catheterization | 1 | 2003 | 236 | 0.190 |
Why?
|
| Neurophysiological Monitoring | 2 | 2018 | 37 | 0.190 |
Why?
|
| Child | 8 | 2024 | 24514 | 0.190 |
Why?
|
| Glycopyrrolate | 1 | 2021 | 9 | 0.190 |
Why?
|
| Survival Rate | 6 | 2020 | 2020 | 0.190 |
Why?
|
| Brain Injuries | 2 | 2019 | 763 | 0.180 |
Why?
|
| Aged | 14 | 2025 | 19456 | 0.180 |
Why?
|
| Electric Countershock | 2 | 2019 | 67 | 0.180 |
Why?
|
| Pulse | 1 | 2021 | 29 | 0.180 |
Why?
|
| Bradycardia | 1 | 2021 | 59 | 0.180 |
Why?
|
| Dexmedetomidine | 1 | 2021 | 44 | 0.180 |
Why?
|
| Oxidative Stress | 1 | 2006 | 813 | 0.180 |
Why?
|
| Coronavirus | 1 | 2020 | 24 | 0.180 |
Why?
|
| Equipment and Supplies, Hospital | 1 | 2020 | 10 | 0.180 |
Why?
|
| Naloxone | 1 | 2020 | 47 | 0.180 |
Why?
|
| Fentanyl | 1 | 2020 | 48 | 0.170 |
Why?
|
| Metformin | 1 | 2022 | 148 | 0.170 |
Why?
|
| Nitrates | 1 | 2020 | 28 | 0.170 |
Why?
|
| Myocardial Stunning | 1 | 2020 | 22 | 0.170 |
Why?
|
| Vasodilation | 2 | 2014 | 189 | 0.170 |
Why?
|
| Brain Edema | 1 | 2020 | 69 | 0.170 |
Why?
|
| Risk Factors | 6 | 2021 | 10134 | 0.170 |
Why?
|
| Betacoronavirus | 2 | 2020 | 285 | 0.170 |
Why?
|
| Patient Positioning | 1 | 2020 | 53 | 0.170 |
Why?
|
| Prescription Drugs | 1 | 2020 | 53 | 0.170 |
Why?
|
| Respiration Disorders | 1 | 2019 | 30 | 0.160 |
Why?
|
| Bacteremia | 1 | 2003 | 406 | 0.160 |
Why?
|
| Cardiolipins | 1 | 2019 | 20 | 0.160 |
Why?
|
| Methylprednisolone | 1 | 2019 | 90 | 0.160 |
Why?
|
| Partial Pressure | 1 | 2018 | 28 | 0.160 |
Why?
|
| Mitochondria, Heart | 1 | 2019 | 60 | 0.160 |
Why?
|
| Metabolomics | 1 | 2022 | 417 | 0.160 |
Why?
|
| Tissue Distribution | 1 | 2019 | 385 | 0.160 |
Why?
|
| Heart Ventricles | 2 | 2020 | 770 | 0.160 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 145 | 0.150 |
Why?
|
| Cyclosporine | 1 | 2019 | 146 | 0.150 |
Why?
|
| Laboratory Personnel | 1 | 2018 | 3 | 0.150 |
Why?
|
| Body Temperature | 4 | 2023 | 114 | 0.150 |
Why?
|
| Pediatrics | 2 | 2024 | 1160 | 0.150 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2020 | 253 | 0.150 |
Why?
|
| Time Factors | 7 | 2018 | 6264 | 0.150 |
Why?
|
| Goals | 1 | 2018 | 129 | 0.150 |
Why?
|
| Hypoxia, Brain | 1 | 2017 | 34 | 0.150 |
Why?
|
| Career Mobility | 1 | 2018 | 50 | 0.150 |
Why?
|
| Microcirculation | 2 | 2014 | 93 | 0.140 |
Why?
|
| Electrocardiography | 2 | 2021 | 968 | 0.140 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2022 | 374 | 0.140 |
Why?
|
| Patient Selection | 2 | 2018 | 688 | 0.140 |
Why?
|
| Blood Gas Analysis | 4 | 2020 | 83 | 0.140 |
Why?
|
| Neurons | 3 | 2016 | 1971 | 0.140 |
Why?
|
| Cytoprotection | 2 | 2007 | 39 | 0.140 |
Why?
|
| Hospitalization | 4 | 2021 | 1753 | 0.140 |
Why?
|
| Cell Survival | 2 | 2016 | 806 | 0.140 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 425 | 0.140 |
Why?
|
| Guanylate Cyclase | 1 | 2016 | 37 | 0.140 |
Why?
|
| Seizures | 2 | 2018 | 878 | 0.130 |
Why?
|
| Free Radical Scavengers | 1 | 2016 | 49 | 0.130 |
Why?
|
| Hypoxia | 2 | 2020 | 246 | 0.130 |
Why?
|
| Healthy Volunteers | 1 | 2017 | 133 | 0.130 |
Why?
|
| Brain Diseases | 1 | 2019 | 301 | 0.130 |
Why?
|
| Secondary Prevention | 1 | 2018 | 214 | 0.130 |
Why?
|
| Point-of-Care Systems | 1 | 2018 | 171 | 0.130 |
Why?
|
| Thermography | 1 | 2016 | 11 | 0.130 |
Why?
|
| Referral and Consultation | 1 | 2020 | 539 | 0.130 |
Why?
|
| Ascorbic Acid | 1 | 2016 | 78 | 0.130 |
Why?
|
| Brain Chemistry | 1 | 2016 | 124 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2022 | 488 | 0.130 |
Why?
|
| Body Temperature Regulation | 1 | 2016 | 42 | 0.130 |
Why?
|
| Transitional Care | 1 | 2016 | 18 | 0.130 |
Why?
|
| Time-to-Treatment | 1 | 2017 | 187 | 0.130 |
Why?
|
| Respiratory Insufficiency | 1 | 2018 | 231 | 0.130 |
Why?
|
| Carbon Monoxide | 1 | 2015 | 27 | 0.120 |
Why?
|
| Cytokines | 1 | 2021 | 1276 | 0.120 |
Why?
|
| Scleroderma, Diffuse | 1 | 2014 | 3 | 0.120 |
Why?
|
| Retrospective Studies | 11 | 2022 | 16223 | 0.120 |
Why?
|
| Shock, Hemorrhagic | 1 | 2015 | 51 | 0.120 |
Why?
|
| Brachial Artery | 1 | 2014 | 39 | 0.120 |
Why?
|
| Injections, Intravenous | 2 | 2018 | 254 | 0.120 |
Why?
|
| Microvessels | 1 | 2014 | 55 | 0.110 |
Why?
|
| Blood Platelets | 1 | 2017 | 324 | 0.110 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2015 | 91 | 0.110 |
Why?
|
| Caspases | 1 | 2015 | 162 | 0.110 |
Why?
|
| Odds Ratio | 3 | 2015 | 1246 | 0.110 |
Why?
|
| Glucose | 2 | 2016 | 885 | 0.110 |
Why?
|
| Swine | 4 | 2019 | 1173 | 0.110 |
Why?
|
| Thermogenesis | 1 | 2014 | 49 | 0.110 |
Why?
|
| Azo Compounds | 1 | 2013 | 8 | 0.110 |
Why?
|
| Anthraquinones | 1 | 2013 | 9 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 4425 | 0.110 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 853 | 0.110 |
Why?
|
| Cardiac Catheterization | 1 | 2018 | 632 | 0.110 |
Why?
|
| Vascular Stiffness | 1 | 2014 | 72 | 0.110 |
Why?
|
| Confidence Intervals | 2 | 2005 | 279 | 0.110 |
Why?
|
| Phenylenediamines | 1 | 2013 | 25 | 0.110 |
Why?
|
| Heart Diseases | 1 | 2018 | 485 | 0.110 |
Why?
|
| Prevalence | 1 | 2020 | 2425 | 0.110 |
Why?
|
| Lung Injury | 1 | 2015 | 123 | 0.110 |
Why?
|
| Pilot Projects | 1 | 2017 | 1399 | 0.110 |
Why?
|
| Clinical Competence | 1 | 2020 | 990 | 0.110 |
Why?
|
| Hospitals, Pediatric | 1 | 2018 | 782 | 0.110 |
Why?
|
| Epinephrine | 3 | 2020 | 177 | 0.100 |
Why?
|
| Acute Disease | 1 | 2016 | 1101 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2014 | 166 | 0.100 |
Why?
|
| Brain Concussion | 1 | 2015 | 229 | 0.100 |
Why?
|
| Cardiology | 1 | 2018 | 478 | 0.100 |
Why?
|
| Nuclear Proteins | 2 | 2022 | 1272 | 0.100 |
Why?
|
| Axons | 1 | 2015 | 396 | 0.100 |
Why?
|
| S-Nitrosothiols | 1 | 2012 | 4 | 0.100 |
Why?
|
| Methemoglobin | 1 | 2012 | 4 | 0.100 |
Why?
|
| Survivors | 1 | 2015 | 344 | 0.100 |
Why?
|
| Prognosis | 3 | 2018 | 4554 | 0.100 |
Why?
|
| Blood Flow Velocity | 1 | 2014 | 436 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 467 | 0.100 |
Why?
|
| Cohort Studies | 2 | 2018 | 4729 | 0.100 |
Why?
|
| Cyclic GMP | 1 | 2012 | 91 | 0.100 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 870 | 0.100 |
Why?
|
| bcl-Associated Death Protein | 1 | 2011 | 4 | 0.100 |
Why?
|
| Endothelium, Vascular | 1 | 2014 | 515 | 0.090 |
Why?
|
| Physicians | 1 | 2018 | 579 | 0.090 |
Why?
|
| Cytochromes c | 1 | 2011 | 51 | 0.090 |
Why?
|
| Sulfonamides | 1 | 2013 | 261 | 0.090 |
Why?
|
| Biomedical Research | 1 | 2017 | 518 | 0.090 |
Why?
|
| Patient Discharge | 3 | 2020 | 495 | 0.090 |
Why?
|
| Neuropsychological Tests | 1 | 2015 | 928 | 0.090 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2012 | 74 | 0.090 |
Why?
|
| Hemoglobins | 2 | 2010 | 306 | 0.090 |
Why?
|
| Aorta | 1 | 2014 | 541 | 0.090 |
Why?
|
| Cell Cycle Proteins | 1 | 2015 | 645 | 0.090 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 577 | 0.090 |
Why?
|
| Astrocytes | 1 | 2013 | 252 | 0.090 |
Why?
|
| Cerebral Cortex | 1 | 2014 | 455 | 0.090 |
Why?
|
| Substance-Related Disorders | 1 | 2015 | 457 | 0.090 |
Why?
|
| Dietary Supplements | 1 | 2014 | 477 | 0.090 |
Why?
|
| Catheter-Related Infections | 1 | 2012 | 131 | 0.090 |
Why?
|
| Reproducibility of Results | 4 | 2018 | 2870 | 0.080 |
Why?
|
| Cognition | 1 | 2015 | 737 | 0.080 |
Why?
|
| Logistic Models | 3 | 2021 | 1802 | 0.080 |
Why?
|
| Treatment Outcome | 6 | 2018 | 12279 | 0.080 |
Why?
|
| Lung | 1 | 2017 | 1482 | 0.080 |
Why?
|
| Mice | 6 | 2022 | 17740 | 0.080 |
Why?
|
| Risk Assessment | 3 | 2018 | 3371 | 0.080 |
Why?
|
| Young Adult | 3 | 2021 | 8972 | 0.080 |
Why?
|
| Oxygen Consumption | 2 | 2023 | 306 | 0.080 |
Why?
|
| Incidence | 3 | 2005 | 3085 | 0.080 |
Why?
|
| Lactic Acid | 2 | 2021 | 147 | 0.070 |
Why?
|
| Anions | 1 | 2007 | 18 | 0.070 |
Why?
|
| Rewarming | 2 | 2017 | 12 | 0.070 |
Why?
|
| Arterial Pressure | 2 | 2021 | 101 | 0.070 |
Why?
|
| Feasibility Studies | 2 | 2020 | 762 | 0.070 |
Why?
|
| International Cooperation | 2 | 2017 | 157 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 2055 | 0.070 |
Why?
|
| Endocrine System | 1 | 2006 | 22 | 0.070 |
Why?
|
| Cell Hypoxia | 1 | 2006 | 95 | 0.070 |
Why?
|
| Cause of Death | 2 | 2018 | 468 | 0.060 |
Why?
|
| Models, Animal | 1 | 2007 | 466 | 0.060 |
Why?
|
| Organ Dysfunction Scores | 2 | 2015 | 48 | 0.060 |
Why?
|
| Glottis | 1 | 2005 | 31 | 0.060 |
Why?
|
| Stroke | 1 | 2012 | 974 | 0.060 |
Why?
|
| Kidney | 2 | 2022 | 1346 | 0.060 |
Why?
|
| Administration, Inhalation | 2 | 2015 | 180 | 0.060 |
Why?
|
| Consensus | 2 | 2017 | 629 | 0.060 |
Why?
|
| Shivering | 1 | 2023 | 2 | 0.050 |
Why?
|
| Equipment Safety | 1 | 2003 | 36 | 0.050 |
Why?
|
| Equipment Contamination | 1 | 2003 | 39 | 0.050 |
Why?
|
| Adolescent | 4 | 2024 | 19350 | 0.050 |
Why?
|
| Staurosporine | 1 | 2022 | 23 | 0.050 |
Why?
|
| Probability | 1 | 2003 | 323 | 0.050 |
Why?
|
| Venous Thrombosis | 1 | 2005 | 181 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 1886 | 0.050 |
Why?
|
| Rodentia | 1 | 2022 | 46 | 0.050 |
Why?
|
| Glutamates | 1 | 2022 | 69 | 0.050 |
Why?
|
| Health Care Costs | 1 | 2005 | 368 | 0.050 |
Why?
|
| Substrate Specificity | 2 | 2014 | 290 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 2015 | 623 | 0.050 |
Why?
|
| Troponin | 1 | 2022 | 72 | 0.050 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2022 | 115 | 0.050 |
Why?
|
| Austria | 1 | 2021 | 19 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2024 | 14074 | 0.050 |
Why?
|
| Equipment Design | 1 | 2003 | 597 | 0.050 |
Why?
|
| Intubation, Intratracheal | 1 | 2005 | 292 | 0.050 |
Why?
|
| Heart Function Tests | 1 | 2021 | 55 | 0.050 |
Why?
|
| Potassium Chloride | 1 | 2020 | 53 | 0.050 |
Why?
|
| Adhesives | 1 | 2020 | 9 | 0.040 |
Why?
|
| Death | 1 | 2021 | 70 | 0.040 |
Why?
|
| Creatinine | 1 | 2022 | 382 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2016 | 2122 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2005 | 1099 | 0.040 |
Why?
|
| Airway Extubation | 1 | 2021 | 67 | 0.040 |
Why?
|
| Macrophages, Peritoneal | 1 | 1999 | 38 | 0.040 |
Why?
|
| Temperature | 1 | 2020 | 304 | 0.040 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 1999 | 35 | 0.040 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1999 | 68 | 0.040 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2019 | 77 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2006 | 723 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2020 | 180 | 0.040 |
Why?
|
| Cardiac Output | 1 | 2019 | 170 | 0.040 |
Why?
|
| Point-of-Care Testing | 1 | 2018 | 27 | 0.040 |
Why?
|
| Classification | 1 | 2018 | 18 | 0.040 |
Why?
|
| Washington | 1 | 2018 | 33 | 0.040 |
Why?
|
| Work Engagement | 1 | 2018 | 4 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 1999 | 168 | 0.040 |
Why?
|
| Time Management | 1 | 2018 | 11 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2022 | 437 | 0.040 |
Why?
|
| Selection Bias | 1 | 2018 | 20 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 1999 | 221 | 0.040 |
Why?
|
| Publication Bias | 1 | 2018 | 13 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2019 | 445 | 0.040 |
Why?
|
| Research Support as Topic | 1 | 2018 | 63 | 0.040 |
Why?
|
| Physicians, Women | 1 | 2018 | 47 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 6467 | 0.040 |
Why?
|
| Hospitals | 1 | 2020 | 396 | 0.040 |
Why?
|
| Catheters | 1 | 2017 | 88 | 0.040 |
Why?
|
| Microscopy, Confocal | 2 | 2014 | 349 | 0.030 |
Why?
|
| Infant | 2 | 2024 | 12474 | 0.030 |
Why?
|
| Mentors | 1 | 2018 | 143 | 0.030 |
Why?
|
| Self Care | 1 | 2018 | 214 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 2020 | 477 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 133 | 0.030 |
Why?
|
| Hospitals, University | 1 | 2016 | 97 | 0.030 |
Why?
|
| Burnout, Professional | 1 | 2018 | 118 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2005 | 3415 | 0.030 |
Why?
|
| Reference Standards | 1 | 2017 | 238 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2020 | 928 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 267 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2018 | 377 | 0.030 |
Why?
|
| Defibrillators, Implantable | 1 | 2018 | 192 | 0.030 |
Why?
|
| Lung Compliance | 1 | 2015 | 19 | 0.030 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2015 | 29 | 0.030 |
Why?
|
| Maze Learning | 1 | 2015 | 128 | 0.030 |
Why?
|
| Microdialysis | 1 | 2015 | 56 | 0.030 |
Why?
|
| Mouth Floor | 1 | 2014 | 1 | 0.030 |
Why?
|
| Length of Stay | 2 | 2014 | 1306 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 459 | 0.030 |
Why?
|
| Manometry | 1 | 2014 | 48 | 0.030 |
Why?
|
| Pulse Wave Analysis | 1 | 2014 | 45 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2022 | 3757 | 0.030 |
Why?
|
| Recurrence | 1 | 2018 | 1425 | 0.030 |
Why?
|
| Fingers | 1 | 2014 | 65 | 0.030 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2014 | 73 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2015 | 314 | 0.030 |
Why?
|
| Nitric Oxide Donors | 1 | 2014 | 22 | 0.030 |
Why?
|
| Basal Metabolism | 1 | 2014 | 94 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 354 | 0.030 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2014 | 56 | 0.030 |
Why?
|
| Echocardiography | 1 | 2019 | 1052 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 2014 | 150 | 0.030 |
Why?
|
| Models, Biological | 2 | 2011 | 1459 | 0.030 |
Why?
|
| Electrodes | 1 | 2013 | 99 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2014 | 117 | 0.030 |
Why?
|
| Multiple Organ Failure | 1 | 2014 | 141 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 1174 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 302 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2013 | 426 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2013 | 286 | 0.030 |
Why?
|
| Disinfectants | 1 | 2012 | 25 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 288 | 0.020 |
Why?
|
| Chlorhexidine | 1 | 2012 | 45 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2019 | 3267 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 1686 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 2976 | 0.020 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2011 | 15 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 1999 | 1530 | 0.020 |
Why?
|
| Arginine | 1 | 2014 | 330 | 0.020 |
Why?
|
| Protein Phosphatase 2 | 1 | 2011 | 29 | 0.020 |
Why?
|
| Checklist | 1 | 2012 | 87 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2015 | 556 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 69 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 754 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2014 | 579 | 0.020 |
Why?
|
| Protein Transport | 1 | 2011 | 368 | 0.020 |
Why?
|
| Cell Line | 1 | 2015 | 2771 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 3054 | 0.020 |
Why?
|
| Phenotype | 1 | 2018 | 4257 | 0.020 |
Why?
|
| Proteomics | 1 | 2011 | 488 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2011 | 1626 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 2534 | 0.020 |
Why?
|
| Biological Transport, Active | 1 | 1999 | 87 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1999 | 98 | 0.010 |
Why?
|
| Antigen Presentation | 1 | 1999 | 103 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 1999 | 117 | 0.010 |
Why?
|
| Endocytosis | 1 | 1999 | 124 | 0.010 |
Why?
|
| Immunization | 1 | 1999 | 307 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1999 | 969 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 1999 | 469 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1999 | 501 | 0.010 |
Why?
|